Copoly.ai
Copoly is an AI-driven company focused on transforming cancer diagnostics and biomedical research. Their flagship product, OncoSage, is a blood-based early cancer detection platform that uses advanced biomarker analysis and machine learning to identify cancer in its earliest stages, providing accurate and timely insights for healthcare providers and patients. Their second product, BioSage, is an AI tool for researchers that analyzes scientific literature and biomedical data to accelerate discovery. Copoly offers AI and Bioinformatics consulting services. The company has been recognized for its innovation, including receiving second place at the BioNext MedTech Innovation Challenge and being selected for talks at Collision 2024.
Copoly.ai
Copoly is an AI-driven company focused on transforming cancer diagnostics and biomedical research. Their flagship product, OncoSage, is a blood-based early cancer detection platform that uses advanced biomarker analysis and machine learning to identify cancer in its earliest stages, providing accurate and timely insights for healthcare providers and patients. Their second product, BioSage, is an AI tool for researchers that analyzes scientific literature and biomedical data to accelerate discovery. Copoly offers AI and Bioinformatics consulting services. The company has been recognized for its innovation, including receiving second place at the BioNext MedTech Innovation Challenge and being selected for talks at Collision 2024.